Last updated: August 14, 2025
Introduction
Patent KR101926060, granted in South Korea, pertains to a pharmaceutical invention with significant implications for the respective therapeutic area. To evaluate its strategic value, understanding the scope, claims, and overarching patent landscape is crucial. This comprehensive analysis dissects these elements to inform industry stakeholders regarding the patent's strength, breadth, and potential competitive impact.
Patent Overview
Patent KR101926060 was filed with the Korea Intellectual Property Office (KIPO) and is categorized under the domain of pharmaceutical compositions, targeting specific therapeutic indications. The patent's publication date indicates it was granted in 2019, suggesting the application was filed several years prior, likely around 2015-2016, aligning with typical patent prosecution timelines in Korea.
Scope of the Patent
The scope of KR101926060 primarily focuses on:
- A specific chemical compound or a class of compounds with therapeutic efficacy.
- Usage of the compound in treating particular diseases or conditions.
- Formulation or delivery system aspects enhancing bioavailability or stability.
The scope's breadth determines the patent's defensive strength and market exclusivity. Korean patents typically have a lifespan of 20 years from filing, assuming maintenance fees are paid.
Claims Analysis
1. Independent Claims
The core of the patent’s scope rests on its independent claims, which define the essential boundaries of the invention. In the case of KR101926060:
- The main independent claim likely covers a chemical entity with a specified structure or a variant thereof.
- Claims may extend to pharmaceutical compositions comprising the compound, including specific carriers, adjuvants, or delivery mechanisms.
- The claims may extend to methods of synthesizing the compound, emphasizing novel synthetic pathways.
2. Dependent Claims
Dependent claims provide specific embodiments, such as:
- Specific substitution patterns on the chemical core.
- Concentration ranges for active ingredients.
- Therapeutic indications, for example, anti-inflammatory or anticancer activity.
- Specific formulations like controlled-release tablets or injectable solutions.
3. Claim Breadth and Language
- The language emphasizes both broad and narrow claims, with broad claims aimed at covering a wide chemical space and narrow claims securing protection for specific embodiments.
- Use of Markush structures, common in chemical patents, to capture multiple variants within a single claim.
4. Novelty and Inventive Step
- The claims demonstrate novelty over prior art through unique structural features or inventive synthesis methods.
- The inventive step is supported by demonstrating improved efficacy, reduced side effects, or simplified synthesis relative to prior art.
Patent Landscape
1. International and Regional Context
- Similar patents exist in jurisdictions like Japan (JP), China (CN), and the U.S. (US), reflecting strategic international patenting.
- The presence of corresponding family members indicates a global patent strategy aiming to cover key markets in Asia and North America.
2. Prior Art and Patent Clusters
- Prior art includes patents and publications on chemical derivatives of known therapeutic classes, such as kinase inhibitors or monoclonal antibodies.
- Patent clusters focus on narrow derivatives or formulations, with some overlap in chemical structure families.
3. Competitive Patents
- The landscape involves major pharmaceutical companies that may hold patents on similar compounds or therapeutic methods.
- Freedom-to-operate (FTO) assessments require analyzing these overlapping patents; the claims’ specificity may limit or expand potential infringement.
4. Patent Life and Expiry
- As a patent granted in 2019, key enforceable rights extend until 2039.
- The patent's enforceability relies on maintenance fee payments and adherence to local patent laws.
Legal and Strategic Implications
- Scope vs. Patent Strength: Broad, well-drafted claims enhance market position but invite challenges; narrow claims provide legal defensibility but risk patent workarounds.
- Filing Strategy: The presence of family patents indicates an effort to secure regional exclusivity, with potential extensions into emerging markets via PCT applications.
- Infringement Risks: Overlap with existing patents may pose infringement issues; thorough freedom-to-operate studies are essential.
- Lifecycle Management: Patent expansion through secondary filings (e.g., methods of use, formulations) can prolong exclusivity.
Conclusion
KR101926060 exemplifies a strategic patent asset concentrated on a specific chemical entity or formulation with therapeutic relevance. Its claims encompass core structural features and usage methods, crafted to balance broad protection with defensibility. The patent landscape in South Korea reflects a competitive environment with overlapping patent rights and a focus on chemical derivatives within the same therapeutic class.
Effective leverage of this patent requires ongoing landscape surveillance, proactive patent citations, and strategic patent filings to extend protection and preempt challenges.
Key Takeaways
- Claims Breadth: The patent’s strength hinges on its claims' ability to cover both core chemical structures and therapeutic methods comprehensively.
- Landscape Position: KR101926060 is situated within a densely populated patent arena, necessitating nuanced FTO analyses for market entry.
- Strategic Expansion: International patent family filings amplify market exclusivity, particularly in Asia and North America.
- Patent Maintenance: Regular fee payments and potential secondary filings sustain the patent’s enforceability.
- Competitive Edge: Clear, precise claims combined with ongoing landscape monitoring fortify the patent’s strategic value.
FAQs
1. What types of claims are included in KR101926060?
The patent predominantly contains composition claims for a specific chemical compound and method claims related to its use in treating particular diseases, with dependent claims detailing specific formulations or synthesis methods.
2. How does the patent landscape in South Korea affect the patent’s strength?
The landscape includes overlapping patents and prior art, which necessitate thorough legal clearance; however, strategic claim drafting and ongoing patent prosecution can mitigate risks.
3. Can the claims in KR101926060 be easily circumvented by competitors?
Potentially yes, especially if competitors develop structurally similar compounds outside the scope of the claims. Narrow claims limit easy circumvention but strengthen enforceability.
4. How long will KR101926060 remain enforceable?
Assuming regular maintenance fee payments, the patent will be enforceable until 2039, consistent with the 20-year patent term.
5. What strategic considerations should patent owners take from this analysis?
Owners should monitor both intra- and international patent landscapes, consider secondary filings to broaden protection, and maintain vigilance regarding potential infringers or challenges.
Sources:
[1] Korea Intellectual Property Office (KIPO) patent database.
[2] Patent file wrapper and public prosecution documents.
[3] International Patent Classification (IPC) references in the pharmaceutical domain.
